Medicare Enrolled

Dr. Catherine Driver, M.D.

Rheumatology · Mission Viejo, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
26732 CROWN VALLEY PKWY STE 151, Mission Viejo, CA 92691
9493476044
In practice since 2007 (19 years)
NPI: 1356469266 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Driver from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Driver? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Driver

Dr. Catherine Driver is a rheumatology specialist in Mission Viejo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Driver performed 39,747 Medicare services across 798 unique beneficiaries.

Between the years covered by Open Payments, Dr. Driver received a total of $16,249 from 47 pharmaceutical and/or device companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Driver is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 13% volume in CA $16,249 industry payments

Medicare Practice Summary

Medicare Utilization ↗
39,747
Medicare services
Top 13% in CA for rheumatology
798
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,092 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
35,600 $4 $15
Denosumab injection (Prolia/Xgeva) 2,400 $18 $34
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
480 $102 $345
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
219 $12 $39
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
144 $1 $16
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
142 $8 $13
C-reactive protein test (inflammation marker)
A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body.
136 $5 $24
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
115 $10 $32
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
113 $8 $43
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
88 $58 $194
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
86 $140 $485
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
51 $61 $196
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
51 $3 $29
Complement and antigen measurement
A laboratory test to measure levels of complement proteins and antigens in the blood.
37 $12 $55
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
29 $3 $13
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
23 $41 $151
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
20 $29 $85
New patient office visit, complex (60-74 min) 13 $161 $591
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
96.7% medium
3.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,249
Total received (2018-2024)
Avg $2,321/year across 7 years
Top 21% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
860
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,249 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,520
2023
$2,868
2022
$2,772
2021
$514
2020
$566
2019
$3,020
2018
$2,988

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$843
ABBVIE INC.
$546
Janssen Biotech, Inc.
$302
Novartis Pharmaceuticals Corporation
$280
Lilly USA, LLC
$252
GlaxoSmithKline, LLC.
$220
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
Fresenius Kabi USA, LLC
$111
Radius Health, Inc.
$102
PFIZER INC.
$92
E.R. Squibb & Sons, L.L.C.
$87
Alexion Pharmaceuticals, Inc.
$72
AstraZeneca Pharmaceuticals LP
$62
UCB, Inc.
$59
Organon Llc
$51
Teva Pharmaceuticals USA, Inc.
$48
SCILEX PHARMACEUTICALS INC.
$44
ANI Pharmaceuticals, Inc.
$41
Alvogen Inc
$36
Sandoz Inc.
$27
Kyowa Kirin, Inc.
$24
Aurinia Pharma U.S., Inc.
$23
Mallinckrodt Hospital Products Inc.
$18
Genentech USA, Inc.
$16
Octapharma USA, Inc.
$16
Top 3 companies account for 48.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,328
Novartis Pharmaceuticals Corporation
$1,522
ABBVIE INC.
$1,242
PFIZER INC.
$1,208
AbbVie Inc.
$1,168
GlaxoSmithKline, LLC.
$1,054
Lilly USA, LLC
$1,009
UCB, Inc.
$821
AbbVie, Inc.
$732
Janssen Biotech, Inc.
$622
Boehringer Ingelheim Pharmaceuticals, Inc.
$411
Celgene Corporation
$390
AstraZeneca Pharmaceuticals LP
$343
E.R. Squibb & Sons, L.L.C.
$305
Radius Health, Inc.
$262
Horizon Therapeutics plc
$232
Genentech USA, Inc.
$200
Fresenius Kabi USA, LLC
$141
Sobi, Inc
$117
Aurinia Pharma U.S., Inc.
$112
Ferring Pharmaceuticals Inc.
$109
MEDEXUS PHARMA, INC.
$108
Alexion Pharmaceuticals, Inc.
$96
Antares Pharma, Inc.
$74
Alvogen Inc
$55
Organon Llc
$51
Teva Pharmaceuticals USA, Inc.
$48
Horizon Pharma plc
$46
SCILEX PHARMACEUTICALS INC.
$44
ANI Pharmaceuticals, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$37
MEDAC PHARMA, INC.
$37
GENZYME CORPORATION
$37
Bioventus LLC
$31
Sandoz Inc.
$27
Hikma Pharmaceuticals USA
$27
Kyowa Kirin, Inc.
$24
Mallinckrodt Hospital Products Inc.
$18
Mallinckrodt LLC
$17
Octapharma USA, Inc.
$16
SANOFI-AVENTIS U.S. LLC
$14
ARBOR PHARMACEUTICALS, INC.
$14
Fidia Pharma USA Inc.
$13
Cumberland Pharmaceuticals, Inc.
$12
FIDIA PHARMA USA INC.
$12
Iroko Pharmaceuticals, LLC
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · CHANTIX · COSENTYX · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · GELSYN 3 · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Horizant · Humira · Hymovis · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TOVIAZ · TREMFYA · Tavneos · Tymlos · UPLIZNA · Uloric · VIVLODEX · XELJANZ · XYOSTED · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Mission Viejo?
Compare rheumatologists in the Mission Viejo area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
74
Per 100K population
2.3
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Driver is a mixed practice specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Driver experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Driver performed 35,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Driver receive payments from pharmaceutical companies?
Yes. Dr. Driver received a total of $16,249 from 47 companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Driver's costs compare to other rheumatologists in Mission Viejo?
Dr. Driver's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Driver) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →